http://purl.org/np/RAOV_EcuL6oHKOUamSF9Mz2linK3j5d4G8WXSU4IgCIj0#Head http://purl.org/np/RAOV_EcuL6oHKOUamSF9Mz2linK3j5d4G8WXSU4IgCIj0 http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAOV_EcuL6oHKOUamSF9Mz2linK3j5d4G8WXSU4IgCIj0#assertion http://purl.org/np/RAOV_EcuL6oHKOUamSF9Mz2linK3j5d4G8WXSU4IgCIj0 http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAOV_EcuL6oHKOUamSF9Mz2linK3j5d4G8WXSU4IgCIj0#provenance http://purl.org/np/RAOV_EcuL6oHKOUamSF9Mz2linK3j5d4G8WXSU4IgCIj0 http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAOV_EcuL6oHKOUamSF9Mz2linK3j5d4G8WXSU4IgCIj0#pubinfo http://purl.org/np/RAOV_EcuL6oHKOUamSF9Mz2linK3j5d4G8WXSU4IgCIj0 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAOV_EcuL6oHKOUamSF9Mz2linK3j5d4G8WXSU4IgCIj0#assertion http://purl.obolibrary.org/obo/DOID_3798 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RAOV_EcuL6oHKOUamSF9Mz2linK3j5d4G8WXSU4IgCIj0#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_3798 http://purl.org/np/RAOV_EcuL6oHKOUamSF9Mz2linK3j5d4G8WXSU4IgCIj0#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RAOV_EcuL6oHKOUamSF9Mz2linK3j5d4G8WXSU4IgCIj0#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB01190 http://purl.org/np/RAOV_EcuL6oHKOUamSF9Mz2linK3j5d4G8WXSU4IgCIj0#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RAOV_EcuL6oHKOUamSF9Mz2linK3j5d4G8WXSU4IgCIj0#association http://www.w3.org/2000/01/rdf-schema#label clindamycin is a lincosamide antibacterial indicated for the treatment of the following 1 1 1 2 1 3 1 4 1 5 1 6 1 7 1 8 limitation of use 1 9 to reduce the development of drug resistant bacteria and maintain the effectiveness of clindamycin in 9 sodium chloride injection and other antibacterial drugs clindamycin in 9 sodium chloride injection should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria 1 1 clindamycin in 9 sodium chloride injection is indicated for the treatment of serious infections caused by susceptible anaerobic bacteria see indications and usage 1 3 1 7 clindamycin in 9 sodium chloride injection is indicated for the treatment of serious infections due to susceptible strains of streptococci pneumococci and staphylococci its use should be reserved for penicillin allergic patients or other patients for whom in the judgment of the physician a penicillin is inappropriate because of the risk of antibacterial associated pseudomembranous colitis see boxed warning bacteriologic studies should be performed to determine the causative organisms and their susceptibility to clindamycin indicated surgical procedures should be performed in conjunction with antibacterial therapy clindamycin in 9 sodium chloride injection is indicated in the treatment of serious lower respiratory tract infections including pneumonia empyema and lung abscess caused by susceptible strains of anaerobes streptococcus pneumoniae e faecalis staphylococcus aureus clindamycin in 9 sodium chloride injection is indicated in the treatment of serious skin and skin structure infections caused by susceptible strains of streptococcus pyogenes staphylococcus aureus clindamycin in 9 sodium chloride injection is indicated in the treatment of serious gynecological infections including endometritis nongonococcal tubo ovarian abscess pelvic cellulitis and postsurgical vaginal cuff infection caused by susceptible anaerobes clindamycin in 9 sodium chloride injection is indicated in the treatment of serious intra abdominal infections including peritonitis and intra abdominal abscess caused by susceptible anaerobic organisms clindamycin in 9 sodium chloride injection is indicated in the treatment of serious septicemia caused by susceptible strains of staphylococcus aureus enterococcus faecalis clindamycin in 9 sodium chloride injection is indicated in the treatment of serious bone and joint infections including acute hematogenous osteomyelitis caused by susceptible strains of staphylococcus aureus since clindamycin does not diffuse adequately into the cerebrospinal fluid clindamycin in 9 sodium chloride injection should not be used in the treatment of meningitis see clinical pharmacology 12 3 to reduce the development of drug resistant bacteria and maintain the effectiveness of clindamycin in 9 sodium chloride injection and other antibacterial drugs clindamycin in 9 sodium chloride injection should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria when culture and susceptibility information are available they should be considered in selecting or modifying antibacterial therapy in the absence of such data local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy http://purl.org/np/RAOV_EcuL6oHKOUamSF9Mz2linK3j5d4G8WXSU4IgCIj0#association https://w3id.org/biolink/vocab/association_type https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation http://purl.org/np/RAOV_EcuL6oHKOUamSF9Mz2linK3j5d4G8WXSU4IgCIj0#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RAOV_EcuL6oHKOUamSF9Mz2linK3j5d4G8WXSU4IgCIj0#association https://w3id.org/biolink/vocab/relation https://schema.org/TreatmentIndication https://identifiers.org/drugbank:DB01190 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RAOV_EcuL6oHKOUamSF9Mz2linK3j5d4G8WXSU4IgCIj0#provenance http://purl.org/np/RAOV_EcuL6oHKOUamSF9Mz2linK3j5d4G8WXSU4IgCIj0#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAOV_EcuL6oHKOUamSF9Mz2linK3j5d4G8WXSU4IgCIj0#pubinfo http://purl.org/np/RAOV_EcuL6oHKOUamSF9Mz2linK3j5d4G8WXSU4IgCIj0#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAOV_EcuL6oHKOUamSF9Mz2linK3j5d4G8WXSU4IgCIj0#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RAOV_EcuL6oHKOUamSF9Mz2linK3j5d4G8WXSU4IgCIj0#sig http://purl.org/nanopub/x/hasSignature aVacqxqfyDU0AZvWkfLgubOF8hCCPS7ivPeUOgDcEFDZxO1FY0nC92zF10I1YH5PeLQbCUvxeZUWCbvFUDM3pgWNc+64JnX1Una3QR6VTgnlDe/VmP0C1SJH9KtHGBCP0h5KXPHWBHYTCvp+Up/mW2F1faU7WO3EFYAnzM9X/Dg= http://purl.org/np/RAOV_EcuL6oHKOUamSF9Mz2linK3j5d4G8WXSU4IgCIj0#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAOV_EcuL6oHKOUamSF9Mz2linK3j5d4G8WXSU4IgCIj0 http://purl.org/np/RAOV_EcuL6oHKOUamSF9Mz2linK3j5d4G8WXSU4IgCIj0 http://purl.org/dc/terms/created 2021-06-12T15:16:41.107+02:00 http://purl.org/np/RAOV_EcuL6oHKOUamSF9Mz2linK3j5d4G8WXSU4IgCIj0 http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAOV_EcuL6oHKOUamSF9Mz2linK3j5d4G8WXSU4IgCIj0 https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RAOV_EcuL6oHKOUamSF9Mz2linK3j5d4G8WXSU4IgCIj0 https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RAOV_EcuL6oHKOUamSF9Mz2linK3j5d4G8WXSU4IgCIj0 https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs